ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
Mersana Therapeutics Inc

Mersana Therapeutics Inc (MRSN)

2.19
0.02
(0.92%)
終値: 11月28日 6:00AM
2.19
-0.005
( -0.23% )
取引時間後: 6:02AM

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

主要統計と詳細

通貨
2.19
買値
2.11
売値
2.25
出来高
615,413
2.11 日の範囲 2.226
1.22 52 週間の範囲 6.2801
時価総額
前日終値
2.17
始値
2.18
最終取引時間
06:02:43
財務取引量
US$ 1,340,223
VWAP
2.1778
平均取引量 (3 か月)
1,070,473
発行済株式数
123,532,909
配当利回り
-
PER
-1.58
1 株当たり利益 (EPS)
-1.39
歳入
36.86M
純利益
-171.67M

Mersana Therapeutics Inc について

Mersana Therapeutics Inc is a clinical stage biopharmaceutical company using its differentiated and proprietary ADC platforms to develop targeted drugs with increased tolerability and expanded opportunities to deliver meaningful clinical benefit to patients. Mersana's product candidate, XMT-1536, is... Mersana Therapeutics Inc is a clinical stage biopharmaceutical company using its differentiated and proprietary ADC platforms to develop targeted drugs with increased tolerability and expanded opportunities to deliver meaningful clinical benefit to patients. Mersana's product candidate, XMT-1536, is in a Phase 1 clinical trial in patients with tumors expressing NaPi2b, including ovarian cancer, NSCLC, and other cancers. In addition, multiple partners are using Mersana's platform to advance their ADC pipelines. 詳細を表示

セクター
Pharmaceutical Preparations
業界
Pharmaceutical Preparations
ウェブサイト
本社
Wilmington, Delaware, USA
設立
-
Mersana Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the ナスダック市場 with ticker MRSN. The last closing price for Mersana Therapeutics was US$2.17. Over the last year, Mersana Therapeutics shares have traded in a share price range of US$ 1.22 to US$ 6.2801.

Mersana Therapeutics currently has 123,532,909 shares in issue. The market capitalisation of Mersana Therapeutics is US$268.07 million. Mersana Therapeutics has a price to earnings ratio (PE ratio) of -1.58.

MRSN 最新ニュース

Mersana Therapeutics Provides Business Update and Announces Third Quarter 2024 Financial Results

Plan to announce initial clinical data for XMT-1660 at a company event by the end of 2024 Dose escalation advancing in Phase 1 clinical trial of XMT-2056 Conference call today at 8:00 a.m. ET...

Mersana Therapeutics to Host Third Quarter 2024 Conference Call on November 13, 2024

CAMBRIDGE, Mass., Nov. 06, 2024 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.06-2.666666666672.252.351.9213315862.08851525CS
40.2714.06251.922.831.814399922.29830215CS
120.7451.03448275861.452.831.2810704732.10557024CS
26-0.19-7.983193277312.382.831.2211992522.00609403CS
520.6239.49044585991.576.28011.2216418962.96106913CS
156-4.96-69.37062937067.159.620.801420723463.48309417CS
260-1.31-37.42857142863.529.090.801416112166.40747478CS

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
BMRABiomerica Inc
US$ 0.4693
(45.70%)
10.25M
ONCOOnconetix Inc
US$ 0.86
(29.91%)
569.17k
BSLKBolt Projects Holdings Inc
US$ 0.3646
(23.18%)
78.14k
ONVOOrganovo Holdings Inc
US$ 0.52
(18.07%)
148.68k
MDAISpectral AI Inc
US$ 1.65
(13.01%)
1.44M
APLTApplied Therapeutics Inc
US$ 1.90
(-77.83%)
9.45M
TOIIWOncology Institute Inc
US$ 0.0135
(-28.57%)
5.82k
CMAXCareMax Inc
US$ 0.31
(-26.45%)
479k
TCBPTC BioPharm Holdings PLC
US$ 0.4901
(-18.32%)
179.02k
IDAIT Stamp Inc
US$ 0.71
(-15.48%)
10.36M
CRKNCrown Electrokinetics Corporation
US$ 0.2989
(7.09%)
12.83M
IDAIT Stamp Inc
US$ 0.71
(-15.48%)
10.36M
BMRABiomerica Inc
US$ 0.4692
(45.67%)
10.25M
PGHLPrimega Group Holdings Ltd
US$ 1.81
(9.70%)
10.17M
APLTApplied Therapeutics Inc
US$ 1.90
(-77.83%)
9.45M

MRSN Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock